Indigenous DES Yet To Consolidate
Even after 50,000 angioplasts being conducted every year in India, the country's
indigenous drug eluting stents (DES) industry is still struggling to consolidate
its position in the market. This is mainly due to lack of adequate support from
established cardiologists, according to a top official of a major indigenous DES
"Though majority of the cardiologists are preferring indigenously built DES,
however, some of the established cardiologists have not supported it the way
they have supported the imported ones," Sahajanand Medical Technologies Private
Limited (SMT) CEO Manish Doshi told PTI here. Based in Gujarat, the company is
one of the largest DES manufacturers in the world, with a customer base spread
over 28 countries. The DES is inserted inside the body to clear the blockages in
heart for preventing cardiac arrest. "This has prevented the market from growing
at a higher rate. World over the trend is promoted by the doctors and
governments of respective countries. South Korea and China are some prime
examples," Doshi said.
He said that this was primarily due to two reasons. "First, we have a habit of
looking at the West for everything and undervalue anything Indian. Secondly, the
Indian DES market is very young. Not many have the trial data of Indian
Companies," he said.
(Ref : The Economic Times dated December 12, 2005)
True Pack To Invest Rs. 8 Cr.
For Advanced Pharma Packaging Plant
True Pack, a dedicated
pharmaceutical packaging major and a leader in the south India, is investing
around Rs 8 crore to set up a state-of-the-art plant close to its present
premises at Peenya Industrial Area in Bangalore. The facility, which is around
60,000 sq. ft. will conform to class 100/10K standards. The first phase of
construction of 20,000 sq. ft. is expected to be completed by March 2006.
The new plant will allow the
company to manufacture of packaging for Small Volume Parenterals, with the
unique halogen-free resin - COC, which is a superior replacement for type I
glass. In addition, it will also manufacture import, substitute containers for
oral solids with DMF No. screw/CRC caps) for the US generic market.
The company's expansion plants
come in the wake of a growing export market for pharma packaging. Currently,
exports, contribute only 10 per cent of its turnover of Rs 16 crore.
True Pack also plans to set up
its own gamma sterilization plant in Bangalore. The 8-year-old True Pack, which
is a part of the London-based Comcraft & Tecapet Group, has pioneered the
concept of design and manufacture of Three Piece Droppers using Injection Blow
Moulding Technology (IBM), which is housed in a modern Class 10K facility at
Bangalore. This product is used for packing ophthalmic, nasal and other oral
(Ref : Chronicle Pharmabiz
dated December 15, 2005)